ClinicalTrials.Veeva

Menu

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

N

Norwegian University of Science and Technology

Status

Active, not recruiting

Conditions

Schizophrenia
Heart; Functional Disturbance
Heart Diseases

Treatments

Diagnostic Test: Cardiac Magnetic Resonance Imaging
Diagnostic Test: Echocardiography
Other: Blood sampling
Diagnostic Test: Electrocardiography

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia.

Full description

Potential participants interested in the study will be screened for eligibility. Those who meet the eligibility criteria will be informed about the study, the expected investigations and its potential risks. All participants giving written informed consent will be enrolled into the study. Participants will be interviewed, given questionnaires, have blood and/or skin samples and clinical parameters taken. Cardiac function parameters will be measured using electrocardiography, echocardiography and magnetic resonance imaging.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with ICD-10 schizophrenia, schizotypal or delusional disorders (F20 to F29)
  • Both inpatient and outpatient
  • Capable of giving informed consent

Exclusion criteria

  • Current or previous diagnosis of cancer
  • Current or previous treatment with chemotherapy
  • Current pregnancy
  • Mothers less than 6 months post-partum

Trial design

120 participants in 2 patient groups

Diagnosed with Schizophrenia
Description:
Patients with a ICD-10 diagnosis of Schizophrenia will undergo investigations to assess cardiac function, cardiovascular disease risk factors and DISC1 mRNA expression. Participants eligible for MRI will be invited to undergo cardiac MRI in addition to echocardiography.
Treatment:
Diagnostic Test: Electrocardiography
Other: Blood sampling
Diagnostic Test: Echocardiography
Diagnostic Test: Cardiac Magnetic Resonance Imaging
No mental health diagnosis
Description:
Participants without a mental health diagnosis will be randomly selected from an existing population registered in the HUNT data and biobank for whom, echocardiographic data and biological samples are available.Those enrolled as controls will be invited to participate in the cardiac MRI portion of the study.
Treatment:
Diagnostic Test: Electrocardiography
Other: Blood sampling
Diagnostic Test: Echocardiography
Diagnostic Test: Cardiac Magnetic Resonance Imaging

Trial contacts and locations

2

Loading...

Central trial contact

Rita Brekke, MD,MSc; Morten A Høydal, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems